Division of Life Science and State Key Laboratory of Molecular Neuroscience, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong SAR, China.
HKUST Shenzhen-Hong Kong Collaborative Innovation Research Institute, Shenzhen 518000, China.
Cancer Biol Med. 2022 Nov 1;19(10):1440-59. doi: 10.20892/j.issn.2095-3941.2022.0418.
Understanding the racial specificities of diseases-such as adult diffuse glioma, the most common primary malignant tumor of the central nervous system-is a critical step toward precision medicine. Here, we comprehensively review studies of gliomas in East Asian populations and other ancestry groups to clarify the racial differences in terms of epidemiology and genomic characteristics. Overall, we observed a lower glioma incidence in East Asians than in Whites; notably, patients with glioblastoma had significantly younger ages of onset and longer overall survival than the Whites. Multiple genome-wide association studies of various cohorts have revealed single nucleotide polymorphisms associated with overall and subtype-specific glioma susceptibility. Notably, only 3 risk loci-5p15.33, 11q23.3, and 20q13.33-were shared between patients with East Asian and White ancestry, whereas other loci predominated only in particular populations. For instance, risk loci 12p11.23, 15q15-21.1, and 19p13.12 were reported in East Asians, whereas risk loci 8q24.21, 1p31.3, and 1q32.1 were reported in studies in White patients. Although the somatic mutational profiles of gliomas between East Asians and non-East Asians were broadly consistent, a lower incidence of amplification in glioblastoma and a higher incidence of 1p19q-- triple-negative low-grade glioma were observed in East Asian cohorts. By summarizing large-scale disease surveillance, germline, and somatic genomic studies, this review reveals the unique characteristics of adult diffuse glioma among East Asians, to guide clinical management and policy design focused on patients with East Asian ancestry.
了解疾病的种族特异性——例如成人弥漫性神经胶质瘤,这是中枢神经系统最常见的原发性恶性肿瘤——是迈向精准医学的关键一步。在这里,我们全面回顾了东亚人群和其他祖先群体的神经胶质瘤研究,以阐明在流行病学和基因组特征方面的种族差异。总的来说,我们观察到东亚人群的神经胶质瘤发病率低于白种人;值得注意的是,与白种人相比,胶质母细胞瘤患者的发病年龄明显更年轻,总生存期更长。对不同队列进行的多项全基因组关联研究揭示了与总体和亚型特异性神经胶质瘤易感性相关的单核苷酸多态性。值得注意的是,仅在东亚和白人患者中共享 5p15.33、11q23.3 和 20q13.33 这 3 个风险位点,而其他位点则主要存在于特定人群中。例如,在东亚人群中报道了风险位点 12p11.23、15q15-21.1 和 19p13.12,而在白人患者的研究中报道了风险位点 8q24.21、1p31.3 和 1q32.1。尽管东亚人和非东亚人的神经胶质瘤体细胞突变谱大致一致,但在东亚人群中观察到胶质母细胞瘤的扩增发生率较低,1p19q-三重阴性低级别神经胶质瘤的发生率较高。通过总结大规模疾病监测、种系和体细胞基因组研究,本综述揭示了东亚成人弥漫性神经胶质瘤的独特特征,以指导针对东亚裔患者的临床管理和政策设计。